These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9295099)

  • 1. NPY opposes PACAP phase shifts via receptors different from those involved in NPY phase shifts.
    Harrington ME; Hoque S
    Neuroreport; 1997 Aug; 8(12):2677-80. PubMed ID: 9295099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
    Gribkoff VK; Pieschl RL; Wisialowski TA; van den Pol AN; Yocca FD
    J Neurosci; 1998 Apr; 18(8):3014-22. PubMed ID: 9526018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
    Yannielli PC; Harrington ME
    J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor.
    Golombek DA; Biello SM; Rendon RA; Harrington ME
    Neuroreport; 1996 May; 7(7):1315-9. PubMed ID: 8817557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian phase shifts to neuropeptide Y In vitro: cellular communication and signal transduction.
    Biello SM; Golombek DA; Schak KM; Harrington ME
    J Neurosci; 1997 Nov; 17(21):8468-75. PubMed ID: 9334419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.
    Huhman KL; Gillespie CF; Marvel CL; Albers HE
    Neuroreport; 1996 May; 7(7):1249-52. PubMed ID: 8817542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the NPY Y5 receptor potentiates circadian responses to light: complementary in vivo and in vitro studies.
    Yannielli PC; Brewer JM; Harrington ME
    Eur J Neurosci; 2004 Feb; 19(4):891-7. PubMed ID: 15009136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro.
    Prosser RA
    Brain Res; 1998 Oct; 808(1):31-41. PubMed ID: 9795117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus.
    Fukuhara C; Brewer JM; Dirden JC; Bittman EL; Tosini G; Harrington ME
    Neurosci Lett; 2001 Nov; 314(3):119-22. PubMed ID: 11704298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
    Lall GS; Biello SM
    Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-induced phase shift in the Syrian hamster (Mesocricetus auratus) is attenuated by the PACAP receptor antagonist PACAP6-38 or PACAP immunoneutralization.
    Bergström AL; Hannibal J; Hindersson P; Fahrenkrug J
    Eur J Neurosci; 2003 Nov; 18(9):2552-62. PubMed ID: 14622156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y blocks GABAB-induced phase-shifts of the suprachiasmatic circadian clock in vitro.
    Biggs KR; Prosser RA
    Brain Res; 1999 Mar; 821(2):461-6. PubMed ID: 10064833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro.
    Biello SM; Golombek DA; Harrington ME
    Neuroscience; 1997 Apr; 77(4):1049-57. PubMed ID: 9130786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.
    Soscia SJ; Harrington ME
    Neurosci Lett; 2005 Jan; 373(3):175-8. PubMed ID: 15619538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylyl cyclase-activating peptide: a pivotal modulator of glutamatergic regulation of the suprachiasmatic circadian clock.
    Chen D; Buchanan GF; Ding JM; Hannibal J; Gillette MU
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13468-73. PubMed ID: 10557344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y applied in vitro can block the phase shifts induced by light in vivo.
    Yannielli PC; Harrington ME
    Neuroreport; 2000 May; 11(7):1587-91. PubMed ID: 10841381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y phase advances the in vitro hamster circadian clock during the subjective day with no effect on phase during the subjective night.
    Harrington ME; Schak KM
    Can J Physiol Pharmacol; 2000 Feb; 78(2):87-92. PubMed ID: 10737670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light.
    Harrington ME; Hoque S; Hall A; Golombek D; Biello S
    J Neurosci; 1999 Aug; 19(15):6637-42. PubMed ID: 10414992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of NPY in the suprachiasmatic nucleus.
    Gamble KL; Paul KN; Karom MC; Tosini G; Albers HE
    Eur J Neurosci; 2006 May; 23(9):2488-94. PubMed ID: 16706855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase.
    Kallingal GJ; Mintz EM
    Neurosci Lett; 2007 Jul; 422(1):59-63. PubMed ID: 17597298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.